Cetya Therapeutics' Seed VC Round

Cetya Therapeutics raised a round of funding on May 09, 2017. Investors include InSynchrony Ventures.

Cetya Therapeutics develops drugs targeting epigenetic mechanisms for unmet medical needs. Cetya works on technology for a series of class I isoform specific histone deacetylase inhibitors that hold s…

Articles about Cetya Therapeutics' Seed VC Round: